Patel Snehal 4
4 · Greenwich LifeSciences, Inc. · Filed Nov 17, 2025
Insider Transaction Report
Form 4
Patel Snehal
DirectorCEO and CFO10% Owner
Transactions
- Award
Stock Options
2025-11-13+100,000→ 2,347,462 totalExercise: $8.20From: 2025-11-13Exp: 2035-11-13→ Common Stock (100,000 underlying)